The Symposium will focus on the opportunities and challenges for those investing and operating in the global life sciences industry. Featuring panels of seasoned dealmakers, industry executives and technical experts who will provide practical guidance on how to navigate the ever-changing life sciences deal landscape, the Symposium will cover today’s hottest growth sectors.
The Symposium, now a “must attend” event for life sciences dealmakers, gives attendees the opportunity to:
- Learn how to best navigate the vibrant and complex life sciences deal landscape
- Hear best practices and success stories from experienced dealmakers
- Connect with other life sciences executives
New in 2018, and exclusively open to venture capital investment professionals, McDermott will also host a half-day VC Investing Bootcamp dedicated to the critical investment issues facing venture capitalists making investments in life sciences startups.
Stop by our session with Stefan Spazek, Capital Advisors Group’s Director of Debt Placement.
Session: Non-Dilutive Funding and Other Unique Capital Sources
Time: 4:00 – 4:45 pm EDT
Location: Royal Sonesta Boston, 40 Edwin H Land Boulevard, Cambridge, MA 02142
Non-dilutive funding can be a key resource for early-stage life sciences companies, financing early operations and R&D, while still allowing founding teams and existing shareholders to retain company ownership and control. This panel will examine sources of non-dilutive funding, both governmental and nongovernmental, and discuss the critical role it plays in today’s life sciences ecosystem as it accelerates product development in the earlystage company environment. Panelists will also discuss how the vetting process involved with securing such funding can provide validation of both team and technology.
- Stefan Spazek, Executive Vice President,
Director of Debt Placement, Capital
- Christian Braemer, Chief Executive Officer,
- Graham Chynoweth, Chief Membership
Officer, Advanced Regenerative
- Karen Gallant, Global R&D Project Director &
Member of the Joint Oversight Committee,
- Justin Yang, Biotech Project Officer,
Biomedical Advanced Research and
- Moderator: Brian Bunn, Partner,
McDermott Will & Emery
For more information or to schedule a meeting, please email firstname.lastname@example.org.